QQ客服 官方微博 反馈留言

	Immune dysregulation in myelodysplastic syndrome: Clinical features, pathogenesis and therapeutic strategies
	Wang, Cong; Yang, Yan; Gao, Sujun; Chen, Jingcheng; Yu, Jinyuan; Zhang, Han; Li, Mingxi; Zhan, Xingying; Li, Wei
刊名	CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
	2018
卷号	122
关键词	Myelodysplastic syndromes Autoimmune diseases Immunosuppressive therapy Checkpoint inhibitors Hypomethylating agents
ISSN号	1040-8428
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3535662
专题	吉林大学白求恩第一医院
推荐引用方式 GB/T 7714	Wang, Cong,Yang, Yan,Gao, Sujun,et al. Immune dysregulation in myelodysplastic syndrome: Clinical features, pathogenesis and therapeutic strategies[J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY,2018,122.
APA	Wang, Cong.,Yang, Yan.,Gao, Sujun.,Chen, Jingcheng.,Yu, Jinyuan.,...&Li, Wei.(2018).Immune dysregulation in myelodysplastic syndrome: Clinical features, pathogenesis and therapeutic strategies.CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY,122.
MLA	Wang, Cong,et al."Immune dysregulation in myelodysplastic syndrome: Clinical features, pathogenesis and therapeutic strategies".CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 122(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。